UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000001246 |
|---|---|
| Receipt number | R000001518 |
| Scientific Title | Randomized phase II trial comparing amrubicine/irinotecan with cisplatin/irinotecan in patients with extensive-stage small-cell lung cancer: (JMTO LC 08-01) |
| Date of disclosure of the study information | 2008/07/15 |
| Last modified on | 2019/03/22 14:59:48 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2008/07/13 04:41:35 | ||
| 2 | Update | 2012/01/14 13:09:59 | Key inclusion criteria |
|
| 3 | Update | 2012/07/14 02:36:34 | Recruitment status Last follow-up date |
|
| 4 | Update | 2012/08/14 20:28:02 | Address TEL Post marketing survey by drug manufacture etc., specified by Japanese law. Address1 Tel1 |
|
| 5 | Update | 2012/08/15 18:48:47 | Address Email1 Institutions |
|
| 6 | Update | 2014/01/14 03:34:43 | Email Last name of contact person Last name of contact person |
|
| 7 | Update | 2014/01/14 03:36:19 | Organization Organization |
|
| 8 | Update | 2014/07/13 14:08:47 | Recruitment status |
|
| 9 | Update | 2019/03/22 14:59:48 | Recruitment status Date of IRB |
